BIOTRONIK ’s New CRT-ICDs Alleviate Atrial Lead Without Sacrificing Diagnostics

BIOTRONIK won FDA approval and is releasing in the U.S. its Intica DX and Intica cardiac resynchronization therapy (CRT)-DX implantable cardioverter defibrillators (ICD). The DX indicator refers to BIOTRONIK’s technology that obviates the neces...

Source: Medgadget - July 19, 2017 Category: Medical Devices Authors: Editors Tags: Cardiology Source Type: blogs